Moderate to Severe Cardiac Impairment
1 clinical trials · Condition
◉ Watch Moderate to Severe Cardiac Impairment
| Record | Firm | Date |
|---|---|---|
| Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure (NCT06651970) | AstraZeneca | 2025-02-04 |
Track Moderate to Severe Cardiac Impairment automatically
Every clearance here is in the API, with alerts when new ones post.